Nov. 29, 2022
Glioblastoma, a rare but deadly brain cancer, is wickedly sturdy. Surgeons remove tumors only to see the cancer come back ferociously. Chemotherapy and radiation therapy have limited effects. About half of patients die within 18 months. But now Virginia Tech scientists have developed a novel 3D tissue-engineered model of the glioblastoma tumor microenvironment that can be used to learn why the tumors return and what treatments will be most effective at eradicating them – right down to a patient-specific level.
We are committed to making our workplace inclusive for everyone. Read our Fralin Biomedical Research Institute Principles of Human Dignity and Non-Discrimination, and Visit our Diversity & Inclusion page for more information.
It is recommended that a well-fitted mask should be worn on the Health Sciences and Technology campus. Read the latest COVID-19 guidelines.
Creating a healthier future. For everyone.
The Fralin Biomedical Research Institute at VTC is one of the nation’s fastest-growing academic biomedical research enterprises and a destination for world-class researchers. The institute’s Virginia Tech scientists focus on diseases that are the leading causes of death and suffering in the United States, including brain disorders, heart disease, and cancer. Since its founding in 2010, the research institute has experienced unprecedented growth: doubling its enterprise and lab facilities in Roanoke, while also investing in brand-new laboratories on the Children’s National Research & Innovation Campus in Washington, D.C.
Home Item2022 Health Sciences and Technology Hokie Pitch , home
Dec. 8, 2022, 1 p.m. | G101A/B, 4 Riverside Circle | 2022 Health Sciences and Technology Hokie Pitch
Home ItemVirtual Seminar: Electrophysiology of Basal Ganglia and Thalamus in Children Undergoing DBS for Dystonia , home
Dec. 9, 2022, 11:00 a.m. | Terence Sanger, M.D., Ph.D., Professor, Departments of Electrical Engineering, Computer Science, and Pediatric Neurology, University of California - Irvine | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Human Neuroscience Research
Home ItemSeminar: Interplay Between AKT and AMPK Signaling in the Regulation of Glucose Homeostasis , home
Dec. 12, 2022, 12 p.m. | Natasha Jaiswal, Ph.D., Senior Research Investigator, Department of Medicine, Perelman School of Medicine, University of Pennsylvania | Seminar
Home ItemSeminar: Regulatory Mechanism of Mitochondrial Organization and Myofibrillar Matrix , home
Dec. 14, 2022, 11 a.m. | Prasanna Katti, Ph.D., Postdoctoral Fellow, Muscle Energetics Lab, National Heart, Lung, and Blood Institute, National Institutes of Health | Seminar
Home ItemIn Person Lecture: Tuning Depression Circuits Using Deep Brain Stimulation , home
December 15, 2022, 5:30 p.m. (Reception at 5 p.m.) | Helen Mayberg, M.D., Professor, Icahn School of Medicine at Mount Sinai and Member, National Academy of Sciences, National Academy of Medicine, American Academy of Arts and Sciences, and National Academy of Inventors | Maury Strauss Distinguished Public Lecture
Home ItemIn Person Seminar: Genetic Drivers in Pancreatic Ductal Adenocarcinoma , home
Jan. 13, 2023, 11 a.m. | Azeddine Atfi, Ph.D., Professor and Chair, Cellular and Molecular Pathogenesis Division, Department of Pathology, Virginia Commonwealth University | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group